Goldman Sachs’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-63,090
| Closed | -$168K | – | 5018 |
|
|
2024
Q1 | $168K | Sell |
63,090
-93,136
| -60% | -$248K | ﹤0.01% | 4371 |
|
|
2023
Q4 | $370K | Buy |
156,226
+77,255
| +98% | +$183K | ﹤0.01% | 4081 |
|
|
2023
Q3 | $111K | Sell |
78,971
-80,034
| -50% | -$112K | ﹤0.01% | 4371 |
|
|
2023
Q2 | $482K | Sell |
159,005
-60,512
| -28% | -$183K | ﹤0.01% | 4007 |
|
|
2023
Q1 | $1.37M | Buy |
219,517
+147,479
| +205% | +$922K | ﹤0.01% | 3458 |
|
|
2022
Q4 | $439K | Sell |
72,038
-127,750
| -64% | -$779K | ﹤0.01% | 4164 |
|
|
2022
Q3 | $2.39M | Sell |
199,788
-11,170
| -5% | -$133K | ﹤0.01% | 3235 |
|
|
2022
Q2 | $2.66M | Buy |
210,958
+142,804
| +210% | +$1.8M | ﹤0.01% | 3216 |
|
|
2022
Q1 | $767K | Buy |
68,154
+11,087
| +19% | +$125K | ﹤0.01% | 4305 |
|
|
2021
Q4 | $1.01M | Sell |
57,067
-37,494
| -40% | -$665K | ﹤0.01% | 4011 |
|
|
2021
Q3 | $2.18M | Buy |
94,561
+79,349
| +522% | +$1.83M | ﹤0.01% | 3424 |
|
|
2021
Q2 | $354K | Sell |
15,212
-2,562
| -14% | -$59.6K | ﹤0.01% | 4619 |
|
|
2021
Q1 | $554K | Sell |
17,774
-42,512
| -71% | -$1.33M | ﹤0.01% | 4284 |
|
|
2020
Q4 | $2.4M | Buy |
+60,286
| New | +$2.4M | ﹤0.01% | 2966 |
|